|
|
Volumn 59, Issue 6, 2005, Pages 670-673
|
|
How children's responses to drugs differ from adults
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIASTHMATIC AGENT;
ANTICONVULSIVE AGENT;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
CHLORAMPHENICOL;
CORTICOSTEROID;
CYCLOSPORIN A;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
PHYTOMENADIONE;
TETRACYCLINE;
THALIDOMIDE;
VALPROIC ACID;
VITAMIN D;
WARFARIN;
ADOLESCENT;
ADRENAL SUPPRESSION;
AGE DISTRIBUTION;
CHILD;
CHILD DEVELOPMENT;
CHILDHOOD DISEASE;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG DESIGN;
DRUG EFFECT;
DRUG INDUCED DISEASE;
DRUG METABOLISM;
DRUG RESEARCH;
GREY BABY SYNDROME;
HUMAN;
HYPOGLYCEMIA;
HYPONATREMIA;
INFANT;
LEARNING DISORDER;
LIVER TOXICITY;
MAMMAL;
NEWBORN;
PATHOPHYSIOLOGY;
PHARMACODYNAMICS;
PHARMACOGENOMICS;
PHOCOMELIA;
PRIORITY JOURNAL;
REVIEW;
SEIZURE;
SIDE EFFECT;
TOOTH DISEASE;
TOOTH STAINING;
ADULT;
AGING;
BAYES THEOREM;
CHILD;
CLINICAL TRIALS;
HUMANS;
PHARMACOGENETICS;
PHARMACOKINETICS;
RESEARCH DESIGN;
|
|
EID: 20644467987
PISSN: 03065251
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1365-2125.2005.02445.x Document Type: Review |
|
Times cited : (138)
|
|
References (7)
|
